Lee SL, Kwan MYW, Murphy C, Chan ELY, Wong JSC, Su. Influenza vaccine effectiveness against influenza-associated hospitalizations in children, Hong Kong, November 2023 to June 2024. Vaccine X. 2024 Oct 6;20:100570
We conducted a test negative study from November 2023 to June 2024, enrolling 4,367 children hospitalized with acute respiratory illness in Hong Kong. Among the children who tested negative for influenza virus and SARS-CoV-2, 56.8 % had received influenza vaccination. Between November 2023 and March 2024, influenza A(H3N2) predominated and the VE against influenza A(H3N2) was estimated as 55 % (95 % CI: 29.6 %, 71.8 %). VE point estimates were higher for younger children than older children. In February to June 2024 influenza A(H1N1) predominated and VE against influenza A(H1N1) was 54 % (95 % CI: 33 %, 69 %) during this period. Influenza B/Victoria circulated at low intensity throughout the 2023/24 season and VE against influenza B was 66 % (95 % CI: 42 %, 80 %). Since its introduction in 2018/19 the school-based influenza vaccination program has substantially increased vaccine uptake in children in Hong Kong and prevented influenza-associated hospitalizations.
See Also:
Latest articles in those days:
- [preprint]Mass mortality at penguin mega-colonies due to avian cholera confounds H5N1 HPAIV surveillance in Antarctica 13 hours ago
- [preprint]How the 1918-1920 Influenza Pandemic Spread Across Switzerland - Spatial Patterns and Determinants of Incidence and Mortality 13 hours ago
- Influenza C Virus in Children With Acute Bronchiolitis and Febrile Seizures 17 hours ago
- Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems 17 hours ago
- Avian Influenza Weekly Update # 1026: 12 December 2025 1 days ago
[Go Top] [Close Window]


